Scalper1 News
Drug stocks were moving on merger news in the stock market today as Forest Laboratories (FRX) forestalled an IPO and NuPathe (PATH) looked to start a bidding war between Endo Health Solutions (ENDP) and Teva Pharmaceutical Industries (TEVA). Forest Labs agreed to pay $2.9 billion for Aptalis, a drugmaker that filed to go public on Dec. 26 after a major reworking by the private equity group TPG Capital. It traded as Axcan Pharma until 2007, when Scalper1 News
Scalper1 News